With 100% gain today, I would be back to even on my small holding. But, my play had nothing to do with the Ablaris compound. I became interested in ARWR because of its IP in RNAi delivery and its admittedly fuzzy notion of being a diversified "nanomedicine company".
Market Data 
Markets 
AI
